[Federal Register Volume 66, Number 155 (Friday, August 10, 2001)]
[Notices]
[Page 42240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-20110]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substance; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 22, 2001, Sigma 
Aldrich Research Biochemicals, Inc., Attn: Richard Milius, 1-3 
Strathmore Road, Natick, Massachusetts 01760, made application by 
renewal to the Drug Enforcement Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
Aminorex (1585)............................  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethlamide (7315)...........  I
Tetrahydrocannabinols (7370)...............  I
4-Bromo-2, 5-dimethoxyamphetamine (7391)...  I
4-Bromo-2,5-dimethoxphenethylamine (7392)..  I
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)...  I
1-[1-(2-Thienyl) cyclohexyl] piperidine      I
 (7470).
Heroin (9200)..............................  I
Normorphine (9313).........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phenylcyclohexylamine (7460)...............  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Diprenorphine (9058).......................  II
Benzoylecgonine (9180).....................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Canfentanil (9773).........................  II
Levo-alphacetylmethadol (LAAM) 9648).......  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
laboratory reference standards and neurochemicals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 9, 2001.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-20110 Filed 8-9-01; 8:45 am]
BILLING CODE 4410-09-M